comparemela.com

Latest Breaking News On - Novel coronaviruses - Page 14 : comparemela.com

Moderna s stock sinks toward record losing streak on COVID-vaccine concerns

Moderna's stock was in danger of breaking its record for consecutive losses as investors expressed increasing caution over slowing sales of COVID vaccines.

Eliana merleHealth care select sectorPfizer incModerna incArticle normalBiotechnology servicesRetail wholesaleHealthcare life sciencesClothing textilesConsumer goodsSpecialized drugs medicationsFinancial performanceSales figuresAnalysts amp 39 comments recommendationsCorporate industrial newsPolitical general news

Opinion: Biotech stocks are in a post-pandemic slump and recovery in 2024 is questionable

Once buoyed by demand for COVID-19 vaccines and treatments, the biotech industry is experiencing a sobering leveling out

United statesErnst youngWall streetFederal trade commissionReduction actArticle opinionRetail wholesaleHealth careClothing textilesConsumer goodsSpecialized drugs medicationsFinancial servicesInvesting securitiesRegulation government policyFinancial performanceAnalyst comment recommendation

Pfizer to more than double price of its COVID antiviral once drug moves to commercial market

The listing price for Paxlovid is more than double what Pfizer charged the federal government during the COVID-19 pandemic.

United statesDave dentonAlbert bourlaUs department of healthPfizer incHuman servicesJournal of the american medical associationWall streetCleveland clinicAmerican medical associationWall street journalChief financial officer dave dentonArticle normalRetail wholesaleHealthcare life sciencesSpecialized drugs medications

Abbott Labs shares rise as company beats earnings estimates, raises full-year guidance

Strong medical device sales boost results even as investors fear obesity drugs' impact.

Abbott laboratoriesArticle normalHealth careFinancial performanceSales figuresEarnings projectionsShare price movement disruptionsCorporate industrial newsPolitical general newsRespiratory tract diseasesSociety communityMedical conditionsOutbreaks epidemicsNovel coronavirusesSocial issuesInfectious diseases

Pfizer Prices Covid Drug Paxlovid at $1,400 for a Five-Day Course

Drugmaker is expected to offer steep discounts to ensure wide access

Wall street journalHealthcare life sciencesNorth americaUnited statesFinancial performanceSales figuresSales promotionsCorporate industrial newsMarkets marketingPolitical general newsRespiratory tract diseasesMedical conditionsOutbreaks epidemicsNovel coronavirusesInfectious diseasesContent types

vimarsana © 2020. All Rights Reserved.